Quarterly report pursuant to Section 13 or 15(d)

Schedule of Effect of Restatement on Financial Statements (Details) (Parenthetical)

v3.23.1
Schedule of Effect of Restatement on Financial Statements (Details) (Parenthetical) - $ / shares
Jun. 30, 2022
Dec. 31, 2021
Preferred stock, no par value $ 0 $ 0
Preferred stock, shares authorized 50,000,000 50,000,000
Common stock, par value $ 0.001 $ 0.001
Common stock, shares authorized 250,000,000 200,000,000
Common stock, shares issued 116,394,806 116,394,806
Common stock, shares outstanding 116,394,806 116,394,806
Series A Preferred Stock [Member]    
Preferred stock, shares issued 9,417,000 9,417,000
Preferred stock, shares outstanding 9,417,000 9,417,000
Series B Preferred Stock [Member]    
Preferred stock, shares issued 6,600,000 6,600,000
Preferred stock, shares outstanding 6,600,000 6,600,000